DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Fresolimumab is an investigational drug.
There have been 5 clinical trials for Fresolimumab. The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2012.
The most common disease conditions in clinical trials are Osteogenesis Imperfecta, Glomerulosclerosis, Focal Segmental, and Brain Neoplasms. The leading clinical trial sponsors are Genzyme, a Sanofi Company, University of California, Los Angeles, and Hospital for Special Surgery, New York.
There are eight US patents protecting this investigational drug and seventy-five international patents.
Recent Clinical Trials for Fresolimumab
|Safety of Fresolimumab in the Treatment of Osteogenesis Imperfecta||Genzyme, a Sanofi Company||Phase 1|
|Safety of Fresolimumab in the Treatment of Osteogenesis Imperfecta||Hospital for Special Surgery, New York||Phase 1|
|Safety of Fresolimumab in the Treatment of Osteogenesis Imperfecta||Hugo W. Moser Research Institute at Kennedy Krieger, Inc.||Phase 1|
Top disease conditions for Fresolimumab
Top clinical trial sponsors for Fresolimumab
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Fresolimumab||Get Started Free||Determination of TGF-.beta. pathway activity using unique combination of target genes||KONINKLIJKE PHILIPS N.V. (Eindhoven, NL)||Get Started Free|
|Fresolimumab||Get Started Free||Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein||CureVac AG (Tubingen, DE)||Get Started Free|
|Fresolimumab||Get Started Free||Cholestosome vesicles for incorporation of molecules into chylomicrons||THERASYN SENSORS, INC. (Eggertsville, NY)||Get Started Free|
|Fresolimumab||Get Started Free||Imaging composition and uses thereof||The University of Melbourne (Melbourne, AU)||Get Started Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Fresolimumab||Australia||AU2015334840||2034-10-24||Get Started Free|
|Fresolimumab||Brazil||BR112017007965||2034-10-24||Get Started Free|
|Fresolimumab||Canada||CA2965442||2034-10-24||Get Started Free|
|Fresolimumab||China||CN107077536||2034-10-24||Get Started Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|